Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

Genoil (GNOLF) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for Genoil (GNOLF) over the last 7 years, with Q3 2025 value amounting to $147005.0.

  • Genoil's Cost of Revenue rose 561.69% to $147005.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$25363.0, marking a year-over-year decrease of 11936.7%. This contributed to the annual value of $560480.0 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Genoil's Cost of Revenue is $147005.0, which was up 561.69% from $147506.0 recorded in Q1 2025.
  • Genoil's 5-year Cost of Revenue high stood at $229966.0 for Q4 2022, and its period low was -$459061.0 during Q4 2024.
  • Over the past 5 years, Genoil's median Cost of Revenue value was $126009.5 (recorded in 2021), while the average stood at $47499.5.
  • The largest annual percentage gain for Genoil's Cost of Revenue in the last 5 years was 25130.85% (2021), contrasted with its biggest fall of 35740.16% (2021).
  • Quarter analysis of 5 years shows Genoil's Cost of Revenue stood at -$358352.0 in 2021, then soared by 164.17% to $229966.0 in 2022, then tumbled by 242.67% to -$328101.0 in 2023, then plummeted by 39.91% to -$459061.0 in 2024, then surged by 132.02% to $147005.0 in 2025.
  • Its Cost of Revenue was $147005.0 in Q3 2025, compared to $147506.0 in Q1 2025 and -$459061.0 in Q4 2024.